Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rix

Showing results (751-760 of 837) with videos related to

Pageof 84
Sort By:
Nature Chemical Biology|October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CMLGeorg E Winter, Uwe Rix, Scott M Carlson, et al.
Medical Care|July 2, 2014
Effect of self-referral on bone mineral density testing and osteoporosis treatmentAmy H Warriner, Ryan C Outman, Adrianne C Feldstein, et al.
Neurodegenerative Disease Management|November 24, 2021
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study designBjörn Oskarsson, Nicholas Maragakis, Richard S Bedlack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
HDAC Inhibition Enhances the <i>In Vivo</i> Efficacy of MEK Inhibitor Therapy in Uveal MelanomaFernanda Faião-Flores, Michael F Emmons, Michael A Durante, et al.
Journal of Medicinal Chemistry|September 25, 2007
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulatorsEsther Martinborough, Yixing Shen, Arjan van Oeveren, et al.
The New Zealand Medical Journal|December 12, 2024
Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New ZealandNicola J Lawrence, Bobbi B Laing, Joseph Tyro, et al.
Neurology|November 26, 2013
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.
Blood|June 18, 2011
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinibKaroline V Gleixner, Matthias Mayerhofer, Sabine Cerny-Reiterer, et al.
Nature Genetics|March 11, 2008
Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndromeCarmen C Leitch, Norann A Zaghloul, Erica E Davis, et al.
Pageof 84

Showing results (751-760 of 837) with videos related to

Sort By:
Pageof 84
Nature Chemical Biology|October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CMLGeorg E Winter, Uwe Rix, Scott M Carlson, et al.
Medical Care|July 2, 2014
Effect of self-referral on bone mineral density testing and osteoporosis treatmentAmy H Warriner, Ryan C Outman, Adrianne C Feldstein, et al.
Neurodegenerative Disease Management|November 24, 2021
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study designBjörn Oskarsson, Nicholas Maragakis, Richard S Bedlack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
HDAC Inhibition Enhances the <i>In Vivo</i> Efficacy of MEK Inhibitor Therapy in Uveal MelanomaFernanda Faião-Flores, Michael F Emmons, Michael A Durante, et al.
Journal of Medicinal Chemistry|September 25, 2007
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulatorsEsther Martinborough, Yixing Shen, Arjan van Oeveren, et al.
The New Zealand Medical Journal|December 12, 2024
Process of development of decentralised clinical trial methodology for cancer clinical trials in Aotearoa New ZealandNicola J Lawrence, Bobbi B Laing, Joseph Tyro, et al.
Neurology|November 26, 2013
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.
Blood|June 18, 2011
KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinibKaroline V Gleixner, Matthias Mayerhofer, Sabine Cerny-Reiterer, et al.
Nature Genetics|March 11, 2008
Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndromeCarmen C Leitch, Norann A Zaghloul, Erica E Davis, et al.
Pageof 84